{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:38:06Z","timestamp":1787891886540,"version":"build-2784847793"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020884","name":"National Agency for Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006255","name":"Universidad de Concepci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006255","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008736","name":"Fondo de Fomento al Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["ID22I10141"],"award-info":[{"award-number":["ID22I10141"]}],"id":[{"id":"10.13039\/501100008736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.tube.2025.102702","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:08:29Z","timestamp":1761185309000},"page":"102702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting HspX of Mycobacterium tuberculosis: Advances in diagnostics, treatment, and vaccine development"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0600-5243","authenticated-orcid":false,"given":"Angela","family":"Hidalgo-Gajardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Mangui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Villavicencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge R.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10181","key":"10.1016\/j.tube.2025.102702_bib1","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","volume":"393","author":"Furin","year":"2019","journal-title":"Tubercul Lancet"},{"key":"10.1016\/j.tube.2025.102702_bib2","article-title":"Roles of mucosal immunity against Mycobacterium tuberculosis infection","volume":"2012","author":"Li","year":"2012","journal-title":"Tuberc Res Treat"},{"key":"10.1016\/j.tube.2025.102702_bib3","series-title":"Global tuberculosis report 2024","year":"2024"},{"key":"10.1016\/j.tube.2025.102702_bib4","first-page":"313","article-title":"Quantity and quality of inhaled dose predicts immunopathology in tuberculosis","volume":"6","author":"Fennelly","year":"2015","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.tube.2025.102702_bib5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.celrep.2016.06.080","article-title":"Microfold cells actively translocate Mycobacterium tuberculosis to initiate infection","volume":"16","author":"Nair","year":"2016","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.tube.2025.102702_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11894-010-0148-6","article-title":"Intraepithelial lymphocytes: to serve and protect","volume":"12","author":"Sheridan","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"issue":"8","key":"10.1016\/j.tube.2025.102702_bib7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.tim.2017.03.007","article-title":"Integrating lung physiology, immunology, and tuberculosis","volume":"25","author":"Torrelles","year":"2017","journal-title":"Trends Microbiol"},{"issue":"11","key":"10.1016\/j.tube.2025.102702_bib8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","article-title":"Anti-tuberculosis treatment strategies and drug development: challenges and priorities","volume":"20","author":"Dartois","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2025.102702_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"O'Garra","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"10.1016\/j.tube.2025.102702_bib10","first-page":"435","article-title":"Comparison of culture, microscopic smear and molecular methods in diagnosis of tuberculosis","volume":"31","author":"Afsar","year":"2018","journal-title":"Rev Esp Quimioter"},{"issue":"1","key":"10.1016\/j.tube.2025.102702_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijmyco.2014.12.006","article-title":"Microscopy as a diagnostic tool in pulmonary tuberculosis","volume":"4","author":"Singhal","year":"2015","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.tube.2025.102702_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jctube.2016.05.005","article-title":"Diagnosis of active tuberculosis disease: from microscopy to molecular techniques","volume":"4","author":"Caulfield","year":"2016","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"10","key":"10.1016\/j.tube.2025.102702_bib13","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s10096-017-3052-2","article-title":"Evaluation of mycotube, a modified version of lowenstein-jensen (LJ) medium, for efficient recovery of Mycobacterium tuberculosis (MTB)","volume":"36","author":"Nambiar","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.tube.2025.102702_bib14","series-title":"The new paradigm of immunity to tuberculosis. Advances in experimental medicine and biology","first-page":"292","author":"Divangahi","year":"2013"},{"issue":"7","key":"10.1016\/j.tube.2025.102702_bib15","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1080\/21645515.2018.1458806","article-title":"The current status, challenges, and future developments of new tuberculosis vaccines","volume":"14","author":"Gong","year":"2018","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tube.2025.102702_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tube.2019.01.003","article-title":"Tuberculosis vaccine candidates based on mycobacterial cell envelope components","volume":"115","author":"Sarmiento","year":"2019","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2025.102702_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tube.2017.06.003","article-title":"Sustained expression of DevR\/DosR during long-term hypoxic culture of","volume":"106","author":"Kumari","year":"2017","journal-title":"Tuberculosis"},{"issue":"13","key":"10.1016\/j.tube.2025.102702_bib18","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.1073\/pnas.121172498","article-title":"Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin","volume":"98","author":"Sherman","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.tube.2025.102702_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/1040841X.2011.606425","article-title":"Understanding the biology of 16 kDa antigen of mycobacterium tuberculosis: scope in diagnosis, vaccine design and therapy","volume":"37","author":"Siddiqui","year":"2011","journal-title":"Crit Rev Microbiol"},{"issue":"4","key":"10.1016\/j.tube.2025.102702_bib20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1365-2958.2004.04450.x","article-title":"The stress-responsive chaperone alpha-crystallin 2 is required for pathogenesis of Mycobacterium tuberculosis","volume":"55","author":"Stewart","year":"2005","journal-title":"Mol Microbiol"},{"issue":"7","key":"10.1016\/j.tube.2025.102702_bib21","first-page":"515","article-title":"Screening of serum biomarkers for distinguishing between latent and active tuberculosis using proteome microarray","volume":"31","author":"Cao","year":"2018","journal-title":"Biomed Environ Sci"},{"issue":"4","key":"10.1016\/j.tube.2025.102702_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/JB.180.4.801-808.1998","article-title":"Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog","volume":"180","author":"Cunningham","year":"1998","journal-title":"J Bacteriol"},{"key":"10.1016\/j.tube.2025.102702_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fmicb.2015.00351","article-title":"Rv2031c of mycobacterium tuberculosis: a master regulator of Rv2028-Rv2031 (HspX) operon","volume":"6","author":"Mushtaq","year":"2015","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.tube.2025.102702_bib24","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.5588\/ijtld.16.0250","article-title":"Active tuberculosis patients have high levels of IgA anti-alpha-crystallin and isocitrate lyase proteins","volume":"20","author":"Talavera-Paulin","year":"2016","journal-title":"Int J Tubercul Lung Dis"},{"issue":"9","key":"10.1016\/j.tube.2025.102702_bib25","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/infdis\/jit595","article-title":"Latency-associated protein Acr1 impairs dendritic cell maturation and functionality: a possible mechanism of immune evasion by Mycobacterium tuberculosis","volume":"209","author":"Siddiqui","year":"2014","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.tube.2025.102702_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1590\/0074-02760140140","article-title":"The use of HspX and GlcB proteins to identify latent tuberculosis in rheumatoid arthritis patients","volume":"109","author":"Silva","year":"2014","journal-title":"Mem I Oswaldo Cruz"},{"key":"10.1016\/j.tube.2025.102702_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2022.102208","article-title":"Nanotechnology and tuberculosis: an old disease with new treatment strategies","volume":"135","author":"Macedo","year":"2022","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"10.1016\/j.tube.2025.102702_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0296448","article-title":"Global adoption of 6-month drug-resistant TB regimens: projected uptake by 2026","volume":"19","author":"Gupta","year":"2024","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.tube.2025.102702_bib29","article-title":"Mycobacterium tuberculosis adaptation in response to isoniazid treatment in a multi-stress system that mimics the host environment","volume":"12","author":"Yimcharoen","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.tube.2025.102702_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tube.2014.11.002","article-title":"HspX knock-out in Mycobacterium tuberculosis leads to shorter antibiotic treatment and lower relapse rate in a mouse model--a potential novel therapeutic target","volume":"95","author":"Hu","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"issue":"16","key":"10.1016\/j.tube.2025.102702_bib31","doi-asserted-by":"crossref","first-page":"9578","DOI":"10.1073\/pnas.95.16.9578","article-title":"3rd, the 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages","volume":"95","author":"Yuan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.tube.2025.102702_bib32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1128\/IAI.74.2.861-868.2006","article-title":"Deletion of the Mycobacterium tuberculosis alpha-crystallin-like hspX gene causes increased bacterial growth in vivo","volume":"74","author":"Hu","year":"2006","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.tube.2025.102702_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10122334","article-title":"Mycobacterium tuberculosis dormancy: how to fight a hidden danger","volume":"10","author":"Salina","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.tube.2025.102702_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.582833","article-title":"Mucosal therapy of multi-drug resistant tuberculosis with IgA and Interferon-gamma","volume":"11","author":"Tran","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2025.102702_bib35","article-title":"Differential levels of anti-mycobacterium tuberculosis-specific IgAs in saliva of household contacts with latent tuberculosis infection","volume":"10","author":"Ruiz-Tagle","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.tube.2025.102702_bib36","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2567.2004.01809.x","article-title":"Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs","volume":"111","author":"Williams","year":"2004","journal-title":"Immunology"},{"issue":"9235","key":"10.1016\/j.tube.2025.102702_bib37","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis","volume":"356","author":"Andersen","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.tube.2025.102702_bib38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10096-005-1362-2","article-title":"Comparison of BacT\/ALERT 3D, Lowenstein-Jensen medium and middlebrook 7H10\/7H11 biplate for recovering mycobacteria from clinical specimens","volume":"24","author":"Adler","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.tube.2025.102702_bib39","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/JCM.42.5.2321-2325.2004","article-title":"Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria","volume":"42","author":"Cruciani","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.tube.2025.102702_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/00365540701522967","article-title":"Comparison of the VersaTREK system and lowenstein-jensen medium for the recovery of mycobacteria from clinical specimens","volume":"40","author":"Falconi","year":"2008","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.tube.2025.102702_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/0255-0857.53203","article-title":"Evaluation of the bactec MGIT 960 TB system for recovery and identification of Mycobacterium tuberculosis complex in a high through put tertiary care centre","volume":"27","author":"Rodrigues","year":"2009","journal-title":"Indian J Med Microbiol"},{"issue":"9","key":"10.1016\/j.tube.2025.102702_bib42","first-page":"985","article-title":"Comparison of the VersaTrek and BACTEC MGIT 960 systems for the contamination rate, time of detection and recovery of mycobacteria from clinical specimens","volume":"5","author":"Yuksel","year":"2011","journal-title":"Afr J Microbiol Res"},{"issue":"10","key":"10.1016\/j.tube.2025.102702_bib43","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1099\/0022-1317-51-10-895","article-title":"An evaluation of the BD ProbeTec ET system for the direct detection of Mycobacterium tuberculosis in respiratory samples","volume":"51","author":"Barrett","year":"2002","journal-title":"J Med Microbiol"},{"issue":"9","key":"10.1016\/j.tube.2025.102702_bib44","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s10096-015-2419-5","article-title":"Performance of the new automated Abbott RealTime MTB assay for rapid detection of Mycobacterium tuberculosis complex in respiratory specimens","volume":"34","author":"Chen","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Pt 8","key":"10.1016\/j.tube.2025.102702_bib45","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1099\/jmm.0.052043-0","article-title":"Evaluation of the Cobas TaqMan MTB real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory specimens","volume":"62","author":"Lee","year":"2013","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.tube.2025.102702_bib46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2334-5-62","article-title":"A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis","volume":"5","author":"Morgan","year":"2005","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.tube.2025.102702_bib47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1128\/JCM.01536-09","article-title":"Commercial DNA probes for mycobacteria incorrectly identify a number of less frequently encountered species","volume":"48","author":"Tortoli","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.tube.2025.102702_bib48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/0255-0857.93034","article-title":"Utility of GenoType MTBDRplus assay in rapid diagnosis of multidrug resistant tuberculosis at a tertiary care centre in India","volume":"30","author":"Raveendran","year":"2012","journal-title":"Indian J Med Microbiol"},{"issue":"2","key":"10.1016\/j.tube.2025.102702_bib49","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/JCM.02128-15","article-title":"Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of mycobacterium species, nocardia species, and other aerobic actinomycetes","volume":"54","author":"Buckwalter","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.tube.2025.102702_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024720","article-title":"Matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry identification of mycobacteria in routine clinical practice","volume":"6","author":"El Khechine","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.tube.2025.102702_bib51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1473-3099(03)00544-9","article-title":"Modern laboratory diagnosis of tuberculosis","volume":"3","author":"Drobniewski","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.tube.2025.102702_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2741\/e845","article-title":"Diagnosis of TB: from conventional to modern molecular protocols","volume":"11","author":"Singh","year":"2019","journal-title":"Front Biosci (Elite Ed)"},{"issue":"2","key":"10.1016\/j.tube.2025.102702_bib53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4046\/trd.2015.78.2.56","article-title":"Diagnosis and treatment of latent tuberculosis infection","volume":"78","author":"Lee","year":"2015","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"3","key":"10.1016\/j.tube.2025.102702_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/adc.2007.129585","article-title":"The tuberculin skin test: a hundred, not out?","volume":"93","author":"Shingadia","year":"2008","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.tube.2025.102702_bib55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1086\/426434","article-title":"Influence of bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size?","volume":"40","author":"Tissot","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.tube.2025.102702_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026827","article-title":"Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.tube.2025.102702_bib57","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1378\/chest.08-2048","article-title":"Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold in tube assay, and T-Spot.TB test in contact investigations for tuberculosis","volume":"135","author":"Diel","year":"2009","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.tube.2025.102702_bib58","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1586\/14737159.6.3.413","article-title":"New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis","volume":"6","author":"Pai","year":"2006","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"10.1016\/j.tube.2025.102702_bib59","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.00114810","article-title":"Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis","volume":"37","author":"Sester","year":"2011","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.tube.2025.102702_bib60","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1183\/09031936.00070611","article-title":"Widespread use of serological tests for tuberculosis: data from 22 high-burden countries","volume":"39","author":"Grenier","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2025.102702_bib61","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coi.2018.04.004","article-title":"Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis","volume":"53","author":"Achkar","year":"2018","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.tube.2025.102702_bib62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tube.2025.102702_bib63","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.3389\/fimmu.2018.02476","article-title":"A systematic review on novel Mycobacterium tuberculosis antigens and their discriminatory potential for the diagnosis of latent and active tuberculosis","volume":"9","author":"Meier","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.tube.2025.102702_bib64","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1074\/jbc.M111.298687","article-title":"Novel mycobacteria antigen 85 complex binding motif on fibronectin","volume":"287","author":"Kuo","year":"2012","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.tube.2025.102702_bib65","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1074\/jbc.273.5.2905","article-title":"The novel fibronectin-binding motif and key residues of mycobacteria","volume":"273","author":"Naito","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tube.2025.102702_bib66","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2017.08.040","article-title":"Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: biology, immune-pathogenicity, applications in diagnosis, and vaccine design","volume":"112","author":"Karbalaei Zadeh Babaki","year":"2017","journal-title":"Microb Pathog"},{"key":"10.1016\/j.tube.2025.102702_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/1365983","article-title":"Lateral flow immunoassay for naked eye detection of Mycobacterium tuberculosis","volume":"2020","author":"Ariffin","year":"2020","journal-title":"J Sens"},{"key":"10.1016\/j.tube.2025.102702_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bios.2013.10.019","article-title":"Gold nanoparticle based tuberculosis immunochromatographic assay: the quantitative ESE quanti analysis of the intensity of test and control lines","volume":"54","author":"Mdluli","year":"2014","journal-title":"Biosens Bioelectron"},{"issue":"10","key":"10.1016\/j.tube.2025.102702_bib69","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/icb.2012.34","article-title":"HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule","volume":"90","author":"Taylor","year":"2012","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"10.1016\/j.tube.2025.102702_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190989","article-title":"IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals","volume":"13","author":"Abebe","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.tube.2025.102702_bib71","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jiph.2015.07.003","article-title":"Evaluation of heat shock proteins for discriminating between latent tuberculosis infection and active tuberculosis: a preliminary report","volume":"9","author":"Shekhawat","year":"2016","journal-title":"J Infect Public Health"},{"issue":"8","key":"10.1016\/j.tube.2025.102702_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181714","article-title":"Detection of anti-HspX antibodies and HspX protein in patient sera for the identification of recent latent infection by Mycobacterium tuberculosis","volume":"12","author":"Castro-Garza","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.tube.2025.102702_bib73","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1021\/acsinfecdis.9b00502","article-title":"Detection and quantification of HspX antigen in sputum samples using plasmonic biosensing: toward a real point-of-care (POC) for tuberculosis diagnosis","volume":"6","author":"Pelaez","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.tube.2025.102702_bib74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tube.2018.07.004","article-title":"Generation and application of DNA aptamers against HspX for accurate diagnosis of tuberculous meningitis","volume":"112","author":"Dhiman","year":"2018","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2025.102702_bib75","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ab.2018.10.019","article-title":"A novel aptamer-based test for the rapid and accurate diagnosis of pleural tuberculosis","volume":"564\u2013565","author":"Kumari","year":"2019","journal-title":"Anal Biochem"},{"issue":"12","key":"10.1016\/j.tube.2025.102702_bib76","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1021\/acsinfecdis.8b00201","article-title":"Aptamer-based TB antigen tests for the rapid diagnosis of pulmonary tuberculosis: potential utility in screening for tuberculosis","volume":"4","author":"Lavania","year":"2018","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.tube.2025.102702_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.726920","article-title":"Development and evaluation of a fusion polyprotein based on HspX and other antigen sequences for the serodiagnosis of tuberculosis","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2025.102702_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2021.102053","article-title":"Serodiagnostic evaluation of fusion proteins from multiple antigens of Mycobacterium tuberculosis for active TB","volume":"127","author":"Arif","year":"2021","journal-title":"Tuberculosis (Edinb)"},{"issue":"8","key":"10.1016\/j.tube.2025.102702_bib79","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/1744666X.2017.1345626","article-title":"Identification of specific antibodies against the Ag85C-MPT51-HspX fusion protein (CMX) for serological screening of tuberculosis in endemic area","volume":"13","author":"Zagmignan","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.tube.2025.102702_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.101981","article-title":"Designing fusion molecules from antigens of Mycobacterium tuberculosis for detection of multiple antibodies in plasma of TB patients","volume":"124","author":"Akhter","year":"2020","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2025.102702_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.830497","article-title":"Peptide-based vaccines for tuberculosis","volume":"13","author":"Gong","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2025.102702_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115767","article-title":"The functions and applications of extracellular vesicles derived from Mycobacterium tuberculosis","volume":"168","author":"Li","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"10.1016\/j.tube.2025.102702_bib83","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1007\/s10096-021-04246-x","article-title":"Hsp16.3 of mycobacterium tuberculosis in exosomes as a biomarker of tuberculosis","volume":"40","author":"Huang","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8986","key":"10.1016\/j.tube.2025.102702_bib84","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2025.102702_bib85","article-title":"Factors influencing the efficacy of Bacille Calmette-Gu\u00e9rin (BCG) vaccine","volume":"6","year":"2025","journal-title":"Microbe"},{"issue":"1","key":"10.1016\/j.tube.2025.102702_bib86","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2469333","article-title":"RNA vaccines: the dawn of a new age for tuberculosis?","volume":"21","author":"Li","year":"2025","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tube.2025.102702_bib87","article-title":"From pathogenesis to antigens: the key to shaping the future of TB vaccines","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2025.102702_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.102021","article-title":"Tuberculosis vaccination needs to avoid 'decoy' immune reactions","volume":"126","author":"Ivanyi","year":"2021","journal-title":"Tuberculosis (Edinb)"},{"issue":"48\u201349","key":"10.1016\/j.tube.2025.102702_bib89","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1016\/j.vaccine.2005.03.056","article-title":"Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis","volume":"23","author":"Khera","year":"2005","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.tube.2025.102702_bib90","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2014.07.041","article-title":"A novel antigen-carrier system: the Mycobacterium tuberculosis Acr protein carried by raw starch microparticles","volume":"474","author":"Moreno-Mendieta","year":"2014","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.tube.2025.102702_bib91","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1128\/IAI.01137-06","article-title":"Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice","volume":"75","author":"Roupie","year":"2007","journal-title":"Infect Immun"},{"issue":"34","key":"10.1016\/j.tube.2025.102702_bib92","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1016\/j.vaccine.2014.06.037","article-title":"Microstructured liposome subunit vaccines reduce lung inflammation and bacterial load after Mycobacterium tuberculosis infection","volume":"32","author":"Trentini","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.tube.2025.102702_bib93","article-title":"Mucosal influenza vector vaccine carrying TB10.4 and HspX antigens provides protection against Mycobacterium tuberculosis in mice and Guinea pigs","volume":"9","author":"Sergeeva","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.tube.2025.102702_bib94","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11515-018-1494-2","article-title":"HspX protein as a candidate vaccine against Mycobacterium tuberculosis: an overview","volume":"13","author":"Yousefi-Avarvand","year":"2018","journal-title":"Front Biol"},{"key":"10.1016\/j.tube.2025.102702_bib95","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.csbj.2023.01.019","article-title":"In silico design of a promiscuous chimeric multi-epitope vaccine against Mycobacterium tuberculosis","volume":"21","author":"Andongma","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"issue":"Web Server issue","key":"10.1016\/j.tube.2025.102702_bib96","doi-asserted-by":"crossref","first-page":"W138","DOI":"10.1093\/nar\/gki357","article-title":"PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands","volume":"33","author":"Reche","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.tube.2025.102702_bib97","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-3083.1998.00420.x","article-title":"Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis","volume":"48","author":"Wilkinson","year":"1998","journal-title":"Scand J Immunol"},{"issue":"2","key":"10.1016\/j.tube.2025.102702_bib98","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1365-2249.2003.02201.x","article-title":"Cytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16-kDa protein","volume":"133","author":"Caccamo","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.tube.2025.102702_bib99","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/eji.200425090","article-title":"Characterization of HLA-DR- and TCR-binding residues of an immunodominant and genetically permissive peptide of the 16-kDa protein of Mycobacterium tuberculosis","volume":"34","author":"Caccamo","year":"2004","journal-title":"Eur J Immunol"},{"issue":"7","key":"10.1016\/j.tube.2025.102702_bib100","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1086\/344174","article-title":"Identification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A\u22170201 CD8(+) T lymphocytes","volume":"186","author":"Caccamo","year":"2002","journal-title":"J Infect Dis"},{"issue":"32","key":"10.1016\/j.tube.2025.102702_bib101","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1016\/j.vaccine.2010.05.063","article-title":"Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein","volume":"28","author":"Shi","year":"2010","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.tube.2025.102702_bib102","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.vaccine.2011.06.029","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice","volume":"30","author":"Yuan","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.tube.2025.102702_bib103","first-page":"909","article-title":"A new DNA vaccine expressing HspX-PPE44-EsxV fusion antigens of Mycobacterium tuberculosis induced strong immune responses","volume":"23","author":"Moradi","year":"2020","journal-title":"Iran J Basic Med Sci"},{"issue":"6","key":"10.1016\/j.tube.2025.102702_bib104","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-3083.2011.02531.x","article-title":"Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice","volume":"73","author":"Li","year":"2011","journal-title":"Scand J Immunol"},{"issue":"51","key":"10.1016\/j.tube.2025.102702_bib105","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1016\/j.vaccine.2011.10.032","article-title":"Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX","volume":"29","author":"Niu","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.tube.2025.102702_bib106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130641","article-title":"Multi-Stage Tuberculosis subunit vaccine candidate LT69 provides high protection against Mycobacterium tuberculosis infection in mice","volume":"10","author":"Niu","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.tube.2025.102702_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2022.152201","article-title":"A novel peptide vaccination augments cytotoxic CD8(+) T-cell responses against Mycobacterium tuberculosis HspX antigen","volume":"227","author":"Lew","year":"2022","journal-title":"Immunobiology"},{"issue":"5","key":"10.1016\/j.tube.2025.102702_bib108","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00284-024-03655-3","article-title":"Production and evaluation of Ag85B:HspX:hFcgamma1 immunogenicity as an Fc fusion recombinant multi-stage vaccine candidate against Mycobacterium tuberculosis","volume":"81","author":"Karbalaei","year":"2024","journal-title":"Curr Microbiol"},{"issue":"1","key":"10.1016\/j.tube.2025.102702_bib109","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41541-024-00847-7","article-title":"BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice","volume":"9","author":"Kwon","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"2","key":"10.1016\/j.tube.2025.102702_bib110","first-page":"156","article-title":"Increasing cellular immune response in liposomal formulations of DOTAP encapsulated by fusion protein Hspx, PPE44, and esxv, as a potential tuberculosis vaccine candidate","volume":"7","author":"Mansury","year":"2019","journal-title":"Rep Biochem Mol Biol"},{"issue":"1","key":"10.1016\/j.tube.2025.102702_bib111","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/08853282221079105","article-title":"Chitosan nanoparticles containing fusion protein (Hspx-PPE44-EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for Mycobacterium tuberculosis","volume":"37","author":"Hoseinpur","year":"2022","journal-title":"J Biomater Appl"},{"issue":"2","key":"10.1016\/j.tube.2025.102702_bib112","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.xphs.2024.11.025","article-title":"Assessment of immunogenicity and protective efficiency of multi-epitope antigen-loaded in mannan decorated PLGA nanoparticles against tuberculosis","volume":"114","author":"Amini","year":"2025","journal-title":"J Pharm Sci"},{"issue":"Pt 1","key":"10.1016\/j.tube.2025.102702_bib113","article-title":"A novel strategy to elicit enduring anti-morphine immunity and relief from addiction by targeting Acr1 protein nano vaccine through TLR-2 to dendritic cells","volume":"274","author":"Nanda","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.tube.2025.102702_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104842","article-title":"Immunogenicity of HspX\/EsxS fusion protein of Mycobacterium tuberculosis along with ISCOMATRIX and PLUSCOM nano-adjuvants after subcutaneous administration in animal model","volume":"154","author":"Yousefi Avarvand","year":"2021","journal-title":"Microb Pathog"},{"key":"10.1016\/j.tube.2025.102702_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105335","article-title":"A new poly(I:C)-decorated PLGA-PEG nanoparticle promotes Mycobacterium tuberculosis fusion protein to induce comprehensive immune responses in mice intranasally","volume":"162","author":"Du","year":"2022","journal-title":"Microb Pathog"},{"issue":"5","key":"10.1016\/j.tube.2025.102702_bib116","first-page":"558","article-title":"Evaluation of the immunotoxicity and allergenicity of a new intranasal influenza vector vaccine against tuberculosis carrying TB10.4 and HspX antigens","volume":"26","author":"Stosman","year":"2023","journal-title":"Iran J Basic Med Sci"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979225000976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979225000976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:38:58Z","timestamp":1781163538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979225000976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":116,"alternative-id":["S1472979225000976"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2025.102702","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting HspX of Mycobacterium tuberculosis: Advances in diagnostics, treatment, and vaccine development","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2025.102702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102702"}}